Visus CEO updates on lead product candidate, 2021 pipeline

Video
Conferences|AAO

Visus Therapeutics CEO Ben Bergo shares an update on the status of its lead product candidate for presbyopia treatment as well as what's in the company's pipeline for 2021.


See more AAO coverage here

Recent Videos
Related Content
Richard Rosen, MD, honored with distinguished award from ASRS

Richard Rosen, MD, honored with distinguished award from ASRS

Article
Ehsan Sadri, MD, leads an ophthalmology innovation discussion with Jeffry Weinhuff of Visionary Ventures

(EyePod) From idea to impact: Navigating ophthalmic innovation

Podcast
ASRS 2024: TEASE-3 study data shows progression stalled in early-stage Stargardt disease patients treated with gildeuretinol

ASRS 2024: TEASE-3 study data shows progression stalled in early-stage Stargardt disease patients treated with gildeuretinol

Article
Podcast: Talking about the anterior segment pipeline for 2023

Podcast: Talking about the anterior segment pipeline for 2023

Podcast
ASRS 2024: Adverum Biotechnologies presenting positive Ixo-vec clinical data from the 26-week interim analysis of the LUNA Phase 2 trial

ASRS 2024: Adverum Biotechnologies presenting positive Ixo-vec clinical data from the 26-week interim analysis of the LUNA Phase 2 trial

Article
ASRS 2024: A look into premier meeting for retina science and innovation

ASRS 2024: A look into premier meeting for retina science and innovation

Article
© 2024 MJH Life Sciences

All rights reserved.